Jazz Pharmaceuticals JAZZ Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | $560.12M+35.0% | $414.83M+285% | -$224.06M+32.0% | ||
| $41.64M+27.1% | $32.75M+7.7% | $30.41M+0.4% | $30.3M+13.4% | ||
| $291.13M+17.4% | $248.05M+9.3% | $226.84M+2.2% | $222M+17.5% | ||
| $1.36B-2.9% | $1.4B+27.8% | $1.09B-14.1% | $1.27B+63.4% | ||
| $58.75M+54.3% | $38.07M+58.9% | $23.96M— | —— | ||
| -$1.51B— | —— | —— | -$450.83M+91.4% | ||
| -$948.82M— | —— | -$305.25M— | —— | ||
| —— | $906.55M+45.1% | $624.83M+115% | $290.03M+162% | ||
| $1.3B-4.5% | $1.36B+27.1% | $1.07B-14.1% | $1.24B+65.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Jazz Pharmaceuticals generate?
- Jazz Pharmaceuticals (JAZZ) generated $1.3B in operating cash flow over the trailing twelve months.
- What is Jazz Pharmaceuticals's free cash flow?
- After $64.6M of capital expenditures, Jazz Pharmaceuticals's free cash flow was $1.3B over the trailing twelve months, down 16.1% year over year.
- Where does Jazz Pharmaceuticals's cash flow data come from?
- Every line is extracted from Jazz Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
